Browse the evidence

Obesogenic food environments disproportionately increase obesity risk for women compared to men due to biological factors (hormonal modulation of taste/storage), gendered marketing targeting women, and structural burdens (unpaid labor/food security) that limit healthy food access.

Recognize that obesity is not just a personal failure but a result of an environment designed to promote weight gain, which affects women differently due to biological and social factors. Focus on structural changes (policy, food environment) rather than just individual willpower. For women, be aware that marketing and household responsibilities may create unique barriers to healthy eating that require specific, gender-responsive solutions.

General obesity does not significantly increase the risk of incident cardiovascular disease (CVD) events in individuals with type 2 diabetes, although it does increase mortality risk.

For people with diabetes, managing weight is less about preventing heart attacks and more about preventing death from any cause. While obesity doesn't significantly increase CVD risk in diabetics, it does increase mortality risk, so weight management remains important.

A healthy vegan diet increases basophil levels in the blood, whereas a healthy omnivorous diet decreases them, indicating diet-specific immune system modulation.

Switching to a healthy vegan diet may alter your immune profile by increasing basophil levels, a type of white blood cell. While this is a specific change, it highlights that plant-based diets actively modulate the immune system rather than just suppressing it.

A healthy vegan diet increases methylation at the ABCG1 locus (potentially elevating Type 2 Diabetes risk) while simultaneously increasing methylation at the PHOSPHO1 locus (potentially reducing Type 2 Diabetes risk), creating a complex and opposing effect on T2D biomarkers.

A healthy vegan diet has complex effects on Type 2 Diabetes biomarkers, increasing methylation at one locus (potentially raising risk) and another (potentially lowering risk). This suggests that the net effect on T2D risk is not straightforward and requires further investigation.

Resistance training does not significantly improve appendicular skeletal muscle mass (ASM) or appendicular skeletal muscle mass index (ASMI) in older adults with sarcopenia.

Do not expect resistance training to significantly increase your muscle mass or muscle mass index if you have sarcopenia. The benefits you feel (strength, balance) are likely due to your nervous system working better, not your muscles getting bigger. This is still a positive outcome for function, even if the scale or tape measure doesn't change much.

Spirulina supplementation does not significantly reduce waist circumference in the general adult population, though it may benefit obese individuals over 40.

Do not expect Spirulina to significantly reduce waist circumference for the general population. However, if you are obese and over 40, taking ≥2g/day may help. Focus on its proven benefits for overall weight and body fat reduction instead.

Public health strategies targeting the obesogenic environment (e.g., SSB taxes, zoning, produce prescriptions) are necessary to support individual weight management efforts, as individual lifestyle advice is undermined by environmental factors.

Individual willpower is not enough in an environment designed to promote obesity. Support public health policies like sugar taxes, zoning for healthy food access, and produce prescription programs. These environmental changes make healthy choices easier and more affordable.

Long-term intermittent fasting (IF) protocols, particularly time-restricted eating (TRE) with short windows (e.g., 8 hours), are associated with increased cardiovascular disease (CVD) mortality and adverse cardiac structural changes, primarily mediated by lean mass loss, circadian misalignment, and reward-based poor dietary choices.

If you practice intermittent fasting, be aware that long-term use (especially with very short eating windows like 8 hours) may increase your risk of heart disease and mortality, particularly if you have existing heart conditions or genetic risks. The benefits seen in short-term studies (less than 12 weeks) do not necessarily translate to long-term health. Focus on preserving muscle mass, eating nutrient-dense foods, and consider combining fasting with exercise or switching to a Mediterranean diet for better long-term cardiovascular outcomes.

Endoscopic Bariatric Procedures (EBP), including intragastric balloon (IGB), aspiration therapy (AT), and primary obesity surgery endoluminal (POSE), are generally less effective than newer OMMs (semaglutide, tirzepatide) and have limited long-term data.

Endoscopic procedures (IGB, AT, POSE, ESG) offer moderate weight loss (3.8-12.8% TBWL) in the short term but are generally less effective than newer medications (semaglutide, tirzepatide) and lack long-term efficacy data. They may be considered for patients who are not candidates for surgery or high-dose medications, but they are not the most effective option for significant, sustained weight loss.

High vegetable intake is inversely associated with cardiovascular disease (CVD) mortality in Japanese women, but this association is not observed in men.

For Japanese women, increasing vegetable intake is associated with a lower risk of dying from heart disease. For men in this specific population, no such link was found. This suggests that while vegetables are generally healthy, their protective effect against heart disease mortality may be sex-dependent.

Manipulations of resistance training variables (such as volume, intensity, or frequency) have a negligible impact on muscle fiber hypertrophy compared to intrinsic biological factors.

Stop obsessing over perfecting your set and rep schemes. Your genetic and biological response to training is the main driver of muscle growth, not whether you do 8 reps or 12. Focus on consistent, hard training and recovery rather than constantly changing variables.

Adipose-derived mesenchymal stem cell (ADMSC) therapy reduces body weight and improves metabolic complications (diabetes, NAFLD) in animal models, though clinical efficacy remains controversial due to low cell survival rates.

ADMSC therapy shows promise in reducing weight and improving metabolic health in animal studies, but it is not yet a standard or proven treatment for humans. Clinical efficacy is controversial, and cell survival after transplantation is low. Patients should not expect this to be a current standard of care.

Geroscience aims to compress the period of morbidity by targeting the fundamental biological mechanisms of aging, rather than treating individual age-related diseases in isolation.

This paper outlines a research strategy, not a direct lifestyle intervention. However, the implication for an individual is that healthspan (the period of life spent in good health) is a distinct and measurable goal from lifespan. Supporting geroscience research involves advocating for and participating in studies that target fundamental aging processes (like cellular senescence or metabolic regulation) rather than just managing symptoms of single diseases as they appear.

Accumulation of Persistent Organic Pollutants (POPs) in adipose tissue is associated with a metabolically unhealthy obesity phenotype, suggesting that environmental toxins may drive metabolic dysfunction and inflammation.

Reducing body fat may help lower your body burden of environmental toxins stored in adipose tissue. Prioritize a diet low in highly processed foods and high-fat animal products, which can be sources of certain POPs, and maintain a healthy weight to minimize the reservoir for these metabolic disruptors.

The protective association of glucosamine against all-cause mortality is significantly stronger in current smokers compared to non-current smokers.

If you smoke and take glucosamine, this study suggests you might derive a greater mortality benefit than non-smokers, possibly because your body has higher inflammation to counteract. However, quitting smoking remains the most effective way to reduce mortality risk.

Frying foods in polyunsaturated fatty acid (PUFA)-rich oils at high temperatures generates cytotoxic and genotoxic lipid oxidation products (LOPs), specifically α,β-unsaturated aldehydes, which significantly increase the risk of chronic non-communicable diseases including cardiovascular disease and cancer.

Avoid frying foods in oils high in polyunsaturated fats (like sunflower, corn, or soybean oil) at high temperatures. These oils break down into toxic aldehydes that increase cancer and heart disease risk. If you must fry, use oils high in saturated or monounsaturated fats (like coconut oil, butter, or avocado oil) as they are more resistant to oxidation, or limit consumption of deep-fried foods.

The concentration of toxic aldehydes (such as trans-2-alkenals and trans,trans-alka-2,4-dienals) in commercially available fried potato chips often exceeds recommended maximum daily intake limits for specific aldehydes like acrolein, posing a significant toxicological risk.

Be aware that fast-food potato chips can contain aldehyde levels exceeding safety guidelines for specific toxins like acrolein. This risk is often higher than the regulated risk of acrylamide. Limiting consumption of deep-fried fast food is the most effective way to reduce exposure to these specific toxins.

Broader access to antiobesity medications (AOM) generates substantial societal value through reduced comorbidities, increased productivity, and improved quality of life, despite current low uptake rates.

For policymakers and payers, expanding access to AOM is a high-value investment. The study shows that increasing uptake to 15-30% among eligible adults generates trillions in societal value through reduced healthcare costs, fewer comorbidities, and better productivity. This supports policy changes to remove barriers to AOM access.

Leucine-enriched whey protein supplementation (20g whey + 3g leucine) post-exercise does not provide additional benefits for sarcopenia, muscle mass, or myokine concentrations compared to resistance training alone in post-hospitalized older adults over 12 weeks.

You do not need to buy leucine-enriched protein supplements to support your resistance training. The study shows that taking 20g of whey protein with 3g of leucine after training did not improve muscle mass or sarcopenia outcomes more than training alone. Save your money and focus on consistent training.

Oral superabsorbent hydrogel (OSH) administration prevents diet-induced obesity and metabolic syndrome in mice by preserving gut barrier integrity and expanding Akkermansia muciniphila.

This research suggests that a specific type of hydrogel, when taken with meals, may help prevent weight gain and metabolic issues by protecting the gut lining and encouraging the growth of beneficial bacteria (A. muciniphila). While promising in mice, this is not yet a proven human therapy. Focus on proven methods like diet and exercise for now.

OSH administration expands Akkermansia muciniphila abundance in the gut microbiota, which is associated with improved metabolic health.

This study shows that OSH can increase the levels of Akkermansia muciniphila, a bacterium linked to better metabolic health, in mice. This is a promising area of research, but it is not yet a proven strategy for humans.

The Elipse swallowable intragastric balloon does not produce clinically significant weight loss or diabetes control in patients with obesity class 1-2 and type 2 diabetes when used in a real-world setting with standard nutritional follow-up.

If you have obesity and type 2 diabetes, this specific swallowable balloon is not a reliable standalone solution for significant weight loss in a standard healthcare setting. It resulted in only ~4% weight loss at 16 weeks, which is minimal compared to surgical options. It may be considered only if you strictly adhere to intensive dietary counseling and accept modest results, but it is not a substitute for more effective interventions.

Chronic inflammation in RA and PsA contributes to increased CVD risk, but the prevalence of Metabolic Syndrome (MetS) alone may not fully account for this risk, particularly in RA where MetS prevalence is similar to the general population.

Having RA or PsA increases your CVD risk beyond just traditional factors like blood pressure or cholesterol. This is partly due to chronic inflammation. Therefore, comprehensive care should address both metabolic risks (like MetS components) and inflammatory control, not just one or the other.

Peak week strategies in non-drug-free bodybuilders, including supraphysiological anabolic steroid use, diuretics, and severe caloric/water restriction, fail to prevent significant losses in lean mass markers and resting metabolic rate.

If you are preparing for a physique competition using performance-enhancing drugs and extreme peak week strategies, be aware that these methods often fail to preserve lean muscle mass and metabolic rate. The combination of high-volume cardio, severe caloric restriction, and polypharmacy can lead to significant muscle loss despite the use of steroids. Individualize your protocol rather than copying a single coach's 'one-size-fits-all' approach, and prioritize muscle preservation over extreme dehydration tactics.